Vivaprime Women 50+
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 50 mcg | Not calculated |
| Vitamine E Source : d-a-tocopheryl acid succinate Potency : 50 UI | 33.5 mg AT | Not calculated |
| bêta-carotène Source : Bêta-carotène tout trans Potency : 875 UI | 525 mcg | Not calculated |
| Biotine Source : Biotine | 56.25 mcg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 18.75 mcg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 16.25 mg | Not calculated |
| Phosphore Source : Phosphate dicalcique | 19.5 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 25 mg | Not calculated |
| Niacine Source : Acide nicotinique | 37.5 mg | Not calculated |
| Cuivre Source : Produit de chélation de composé cuivrique et de PVH | 300 mcg | Not calculated |
| Tagetes erecta Source : Fleur Potency : 1.5 mg lutein esters | 7.5 mg | Not calculated |
| Tagetes erecta Source : Fleur Potency : 0.3 mg zeaxanthin esters | Not specified | Not calculated |
| Passiflora incarnata Source : Herb top extract Potency : 4 % flavones | 7.5 mg | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique | 25.48 mg | Not calculated |
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 3 mg | Not calculated |
| Vitis vinifera Source : Seed (standardized extract) Potency : 95 % proanthocyanidins | 6.25 mg | Not calculated |
| Lécithine Source : Huile de soja | 6.25 mg | Not calculated |
| Eleutherococcus senticosus Source : Extrait de racine Extraction ratio : 4:1 Dry plant equivalent : 30 mg Potency : 1 % eleutherosides | 7.5 mg | Not calculated |
| Potassium Source : Chlorure de potassium | 25 mg | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose, gomme de guar, Dioxyde de silicium, propylèneglycol, Stéarate de magnésium, Hydroxypropyl methylcellulose, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamin A to help maintain eyesight, skin membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Helps in the development and maintenance of bones and teeth. An antioxidant for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development. Helps to produce red blood cells. Helps to maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Helps to produce and repair connective tissue. Helps to form red blood cells. Provides support for healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Mission Vivacare Inc.
- NPN or DIN-HM
- 80035211
- Status
- Active licence
- Licence date
- 31 August 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80035211
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Passiflora incarnata
Read the warning, when it applies and the studies cited
PASSIONFLOWER -PASSIFLORA INCARNATA
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).
Sources cited by Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002
Condition of application: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
- Lécithine
Read the warning, when it applies and the studies cited
- Eleutherococcus senticosus
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vivaprime Women 50+”, https://compoatlas.com/en/supplements/canada/80035211-vivaprime-women-50, updated 31 August 2012.